Bod Science Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Bod Science has a total shareholder equity of A$-703.4K and total debt of A$963.1K, which brings its debt-to-equity ratio to -136.9%. Its total assets and total liabilities are A$3.5M and A$4.2M respectively.

Anahtar bilgiler

-136.9%

Borç/özkaynak oranı

AU$963.13k

Borç

Faiz karşılama oranın/a
NakitAU$2.03m
Eşitlik-AU$703.36k
Toplam yükümlülüklerAU$4.21m
Toplam varlıklarAU$3.50m

Son finansal sağlık güncellemeleri

Recent updates

Here's Why We're Watching Bod Australia's (ASX:BDA) Cash Burn Situation

Sep 23
Here's Why We're Watching Bod Australia's (ASX:BDA) Cash Burn Situation

Bod Australia (ASX:BDA) Is In A Good Position To Deliver On Growth Plans

Jun 07
Bod Australia (ASX:BDA) Is In A Good Position To Deliver On Growth Plans

Why Bod Australia's (ASX:BDA) CEO Pay Matters

Feb 22
Why Bod Australia's (ASX:BDA) CEO Pay Matters

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: BOD has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Uzun Vadeli Yükümlülükler: BOD has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: BOD has negative shareholder equity, which is a more serious situation than a high debt level.

Borcun Azaltılması: BOD's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Bilanço


Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: BOD has sufficient cash runway for 4 months based on last reported free cash flow, but has since raised additional capital.

Tahmini Nakit Akışı: BOD is forecast to have sufficient cash runway for 4 months based on free cash flow estimates, but has since raised additional capital.


Sağlıklı şirketleri keşfedin